Evidence map›Paper›PMID 35890152›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

A New Approach for the Development of Multiple Cardiovascular Risk Factors in Two Rat Models of Hypertension.

Karyne Garcia Tafarelo Moreno, Aline Aparecida Macedo Marques, Gabriela Pereira da Silva, Bethânia Rosa Lourençone, Clara Soligo Fortini, Patrícia Regina Terço Leite, Ariany Carvalho Dos Santos, Roosevelt Isaías Carvalho Souza, Leila Isabel da Siva, Arquimedes Gasparotto Junior

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Karyne Garcia Tafarelo MorenoLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.ORCID 0000-0003-0725-7805
Aline Aparecida Macedo MarquesLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Gabriela Pereira da SilvaLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.ORCID 0000-0001-8449-3620
Bethânia Rosa LourençoneLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Clara Soligo FortiniLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Patrícia Regina Terço LeiteLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Ariany Carvalho Dos SantosLaboratory of Histopathology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Roosevelt Isaías Carvalho SouzaLaboratory of Histopathology, Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.
Leila Isabel da SivaPost-Graduate Program in Biotechnology Applied to Agriculture, Paranaense University, Umuarama 87502-210, Brazil.
Arquimedes Gasparotto JuniorLaboratory of Cardiovascular Pharmacology (LaFAC), Faculty of Health Sciences, Federal University of Grande Dourados, Dourados 79825-070, Brazil.ORCID 0000-0003-3433-5098
Universidade Federal da Grande Dourados · BRUniversidade Paranaense · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior NoneFundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul 71/700.135/2018National Council for Scientific and Technological Development 407685/2018-9
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is the leading cause of death among non-communicable diseases. There is a lack of valid animal models that mimic associations among multiple cardiovascular risk factors in humans. The present study developed an animal model that uses multiple cardiovascular risk factors-namely, hypertension, hypothyroidism, and a high-fat diet (HFD). Two models of hypertension were used: renovascular hypertension (two-kidney, one clip [2K1C]) and spontaneously hypertensive rats (SHRs). The naive group was composed of normotensive rats. Twelve weeks after surgery to induce renovascular hypertension, rats in the 2K1C and SHR groups underwent thyroidectomy. The HFD was then implemented for 6 weeks. Renal function, serum redox status, biochemical CVD markers, electrocardiographic profile, blood pressure, mesenteric vascular bed reactivity, histopathology, and morphometry were investigated. Both experimental models induced dyslipidemia, renal function impairment, and hepatic steatosis, accompanied by higher levels of different inflammatory markers and serum oxidative stress. These alterations contributed to end-organ damage in all hypertensive rats. Our findings corroborate a viable alternative model that involves multiple cardiovascular risk factors and resembles conditions that are seen in humans. Both models mimicked CVD, but our data show that SHRs exhibit more significant pathophysiological changes.

Indexed as

animal modelscardiovascular diseasedyslipidemiarenal impairment

Identifiers

PMID35890152
PMCPMC9318210
OpenAlexW4285092512

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.